Cargando…
SARS-CoV-2 full length spike protein for COVID-19 vaccine development and diagnostic testing
Autores principales: | Richardson, Crystal, Abhyankar, Mayuresh, Bracaglia, Jillian, Agah, Sayeh, Schuhmacher, Zachary, Smith, Bryan, Wuenschmann, Sabina, Petri, William, Chapman, Martin, Pomes, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849597/ http://dx.doi.org/10.1016/j.jaci.2020.12.546 |
Ejemplares similares
-
An effective approach for recombinant production of select SARS-CoV-2 proteins in Escherichia coli
por: Agah, Sayeh, et al.
Publicado: (2021) -
Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
por: Abhyankar, Mayuresh M., et al.
Publicado: (2021) -
PCR Amplification and Sequencing Analysis of Full-Length Turkey Coronavirus Spike Gene
por: Chen, Yi-Ning, et al.
Publicado: (2015) -
Stability and flexibility of full-length human oligodendrocytic QKI6
por: Raasakka, Arne, et al.
Publicado: (2019) -
Unique allergen-specific human IgE monoclonal antibodies derived from patients with allergic disease
por: Smith, Bryan R. E., et al.
Publicado: (2023)